Related Experiment Video
Updated: Jun 20, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice
Xinle Wu1, Hongfei Ge, Bryan Lemon
1Amgen Inc, South San Francisco, CA 94080, USA. xinlew@amgen.com
Abstract:
FGF19 is a hormone that regulates bile acid and glucose homeostasis. Progress has been made in identifying cofactors for receptor activation. However, several functions of FGF19 have not yet been fully defined, including the actions of FGF19 on target tissues, its FGF receptor specificity, and the contributions of other cofactors, such as heparin. Here, we explore the requirements for FGF19-FGFR/co-receptor interactions and signaling in detail. We show that betaKlotho was essential for FGF19 interaction with FGFRs 1c, 2c, and 3c, but FGF19 was able to interact directly with FGFR4 in the absence of betaKlotho in a heparin-dependent manner. Further, FGF19 activated FGFR4 signaling in the presence or absence of betaKlotho, but activation of FGFRs 1c, 2c, or 3c was completely betaKlotho dependent. We then generated an FGF19 molecule, FGF19dCTD, which has a deletion of the C-terminal region responsible for betaKlotho interaction. We determined that betaKlotho-dependent FGFR1c, 2c, and 3c interactions and activation were abolished, and betaKlotho-independent FGFR4 activation was preserved; therefore, FGF19dCTD is an FGFR4-specific activator. This unique FGF19 molecule specifically activated FGFR4-dependent signaling in liver and suppressed CYP7A1 expression in vivo, but was unable to activate signaling in adipose where FGFR4 expression is very low. Interestingly, unlike FGF19, treatment of ob/ob mice with FGF19dCTD failed to improve glucose levels and insulin sensitivity. These results suggest that FGF19-regulated liver bile acid metabolism could be independent of its glucose-lowering effect, and direct FGFR activation in adipose tissue may play an important role in the regulation of glucose homeostasis.
Insights
Fibroblast Growth Factor 19 (FGF19) interactions with its receptors are complex. A modified FGF19 (FGF19dCTD) specifically activates FGFR4, impacting liver bile acid regulation but not glucose homeostasis.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Regulation
Background:
- Fibroblast Growth Factor 19 (FGF19) is a hormone crucial for bile acid and glucose homeostasis.
- Understanding FGF19's receptor specificity and cofactor requirements, like betaKlotho and heparin, is essential for defining its functions.
- Previous research highlighted progress in identifying cofactors but left several FGF19 actions undefined.
Purpose of the Study:
- To investigate the specific requirements for FGF19-Fibroblast Growth Factor Receptor (FGFR) interactions and signaling.
- To elucidate the roles of betaKlotho and heparin in mediating FGF19's effects on different FGFRs.
- To develop and characterize a novel FGF19 variant (FGF19dCTD) with specific FGFR4 activation properties.
Main Methods:
- Investigated FGF19 binding and signaling across various FGFRs (FGFR1c, FGFR2c, FGFR3c, FGFR4) in the presence and absence of betaKlotho and heparin.
- Generated a modified FGF19 molecule, FGF19dCTD, by deleting the C-terminal domain responsible for betaKlotho interaction.
- Administered FGF19 and FGF19dCTD to ob/ob mice to assess in vivo effects on liver gene expression (CYP7A1), glucose levels, and insulin sensitivity.
Main Results:
- BetaKlotho is essential for FGF19 interaction with FGFR1c, FGFR2c, and FGFR3c, but not for FGFR4 interaction, which is heparin-dependent.
- FGF19 activates FGFR4 signaling with or without betaKlotho, while FGFR1c, FGFR2c, and FGFR3c activation is strictly betaKlotho-dependent.
- FGF19dCTD selectively activated FGFR4 signaling in the liver, suppressed CYP7A1 expression, but did not improve glucose levels or insulin sensitivity in mice, unlike native FGF19.
Conclusions:
- FGF19's regulation of liver bile acid metabolism may be independent of its glucose-lowering effects.
- Direct FGFR4 activation in adipose tissue might be critical for glucose homeostasis, suggesting distinct roles for FGF19 signaling pathways.
- FGF19dCTD serves as a valuable tool for dissecting FGF19 signaling pathways, particularly highlighting the specific role of FGFR4 in hepatic functions.
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
